Last week, @SkyJacquie visited the @ICR_London and met the scientists who led the early research into the breast cancer drug she credits with keeping her alive.
https://t.co/G8c2f5eOo2
Lovely interview in @GlamourMagUK with Sally Swift from the @BreastCancerNow Toby Robins Research Centre at the ICR, where she talks about her role in the team that discovered #BRCA2, and careers for #WomenInScience.
Read it here 👇 https://t.co/XzvbYZvuP7
"We worked day and night with a shared passion to win the race to discover the #BRCA2 gene."
Sally Swift was part of the team that made the BRCA2 #Cancer gene discovery in 1995. We recently celebrated their achievement by unveiling a plaque at our laboratories.
#WorldCancerDay
@MartinSLewis@itvMLshow My mum offered loads of advice when my eldest daughter was born almost 21 yrs ago - one was not to lock away the kids money in case we needed to borrow it for things we wanted for them/they wanted which we couldn’t afford right then. Never had to do it, but makes perfect sense
Our ground-breaking research is focused entirely on breast cancer.
Right now, we’re funding almost £24 million worth of research projects. For the first time since the pandemic, this year we are funding 11 new research projects across the UK and Ireland.
@LizWalker72@silverpebble These words sum up my experience of becoming a single mum - keep hold of your values, love your kids hard and go easy on yourself. You will see the light again.
@royalwindsortri can anybody help with our registrations for Sunday please? We are 2 teams having issues with registration numbers and British Tri licenses for the day. Radio silence from @HumanRaceEvents on all platforms. Obviously needs to be sorted
@HumanRaceEvents can anybody please help with wonky registrations for the Windsor Tri this weekend? We’re 2 teams, issues with reg numbers and BTri day licenses?? No response to email
"As a research scientist, this is everything you dream about." - Professor Chris Lord (@IcrLordLab).
New results show that the targeted drug, olaparib improves survival in women with high-risk, early-stage #BreastCancer who have inherited faults in their #BRCA1 or #BRCA2 genes.